CareRx Corp
TSX:CRRX
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.15
2.41
|
Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one CRRX stock under the Base Case scenario is 3.8 CAD. Compared to the current market price of 2 CAD, CareRx Corp is Undervalued by 47%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
CareRx Corp
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for CRRX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
CareRx Corp
Balance Sheet Decomposition
CareRx Corp
Current Assets | 60.2m |
Cash & Short-Term Investments | 7.2m |
Receivables | 32.7m |
Other Current Assets | 20.3m |
Non-Current Assets | 158.4m |
PP&E | 49.5m |
Intangibles | 108.9m |
Current Liabilities | 60.7m |
Accounts Payable | 28.4m |
Accrued Liabilities | 16.6m |
Other Current Liabilities | 15.6m |
Non-Current Liabilities | 77.7m |
Long-Term Debt | 75.1m |
Other Non-Current Liabilities | 2.6m |
Earnings Waterfall
CareRx Corp
Revenue
|
366.6m
CAD
|
Cost of Revenue
|
-260m
CAD
|
Gross Profit
|
106.5m
CAD
|
Operating Expenses
|
-97.9m
CAD
|
Operating Income
|
8.7m
CAD
|
Other Expenses
|
-15.7m
CAD
|
Net Income
|
-7m
CAD
|
Free Cash Flow Analysis
CareRx Corp
CAD | |
Free Cash Flow | CAD |
CRRX Profitability Score
Profitability Due Diligence
CareRx Corp's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
CareRx Corp's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
CRRX Solvency Score
Solvency Due Diligence
CareRx Corp's solvency score is 27/100. The higher the solvency score, the more solvent the company is.
Score
CareRx Corp's solvency score is 27/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CRRX Price Targets Summary
CareRx Corp
According to Wall Street analysts, the average 1-year price target for CRRX is 4.01 CAD with a low forecast of 2.53 CAD and a high forecast of 5.51 CAD.
Dividends
Current shareholder yield for CRRX is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
CareRx Corp. engages in the provision of pharmacy and other healthcare services. The company is headquartered in Toronto, Ontario and currently employs 1,378 full-time employees. The company went IPO on 2002-09-04. The firm provides services in rural and urban areas throughout Ontario, Alberta, British Columbia, and parts of Saskatchewan. The firm serves long-term care, retirement and assisted living, and supportive housing and group homes. The company offers a range of technology and program solutions, which includes eMAR Integration, Digital Prescribing, Nursing Portal and Karie Medication Dispenser.
Contact
IPO
Employees
Officers
The intrinsic value of one CRRX stock under the Base Case scenario is 3.8 CAD.
Compared to the current market price of 2 CAD, CareRx Corp is Undervalued by 47%.